The prognostic value of liver tumor T cell infiltrates.

PubWeight™: 0.81‹?›

🔗 View Article (PMC 4134707)

Published in J Surg Res on June 07, 2014

Authors

Hadi Khan1, Venu G Pillarisetty2, Steven C Katz3

Author Affiliations

1: Department of Surgery, Roger Williams Medical Center, Providence, Rhode Island.
2: Department of Surgery, University of Washington School of Medicine, Seattle, Washington.
3: Department of Surgery, Roger Williams Medical Center, Providence, Rhode Island; Department of Surgery, Boston University School of Medicine, Boston, Massachusetts. Electronic address: skatz@chartercare.org.

Articles cited by this

Control of regulatory T cell development by the transcription factor Foxp3. Science (2003) 40.32

Safety and activity of anti-PD-L1 antibody in patients with advanced cancer. N Engl J Med (2012) 35.24

Specific recruitment of regulatory T cells in ovarian carcinoma fosters immune privilege and predicts reduced survival. Nat Med (2004) 22.96

Clinical score for predicting recurrence after hepatic resection for metastatic colorectal cancer: analysis of 1001 consecutive cases. Ann Surg (1999) 14.31

A new approach to the adoptive immunotherapy of cancer with tumor-infiltrating lymphocytes. Science (1986) 8.07

Actual 10-year survival after resection of colorectal liver metastases defines cure. J Clin Oncol (2007) 4.95

Technical aspects of immunohistochemistry. Vet Pathol (2005) 3.51

The prognostic influence of tumour-infiltrating lymphocytes in cancer: a systematic review with meta-analysis. Br J Cancer (2011) 3.45

Identification of specific cytolytic immune responses against autologous tumor in humans bearing malignant melanoma. J Immunol (1987) 3.03

Hepatic neuroendocrine metastases: does intervention alter outcomes? J Am Coll Surg (2000) 2.60

Hepatic suppression of sensitization to antigen absorbed into the portal system. Nature (1967) 2.35

Liver dendritic cells are less immunogenic than spleen dendritic cells because of differences in subtype composition. J Immunol (2004) 1.81

Factors linked to early recurrence of small hepatocellular carcinoma after hepatectomy: univariate and multivariate analyses. Hepatology (1991) 1.63

Tumor-infiltrating T lymphocytes: friends or foes? Lab Invest (2006) 1.56

Tumor-infiltrating lymphocytes in colorectal tumors display a diversity of T cell receptor sequences that differ from the T cells in adjacent mucosal tissue. Cancer Immunol Immunother (2013) 1.53

Tissue microarrays: a new approach for quality control in immunohistochemistry. J Clin Pathol (2002) 1.49

Interleukin 2 expanded tumor-infiltrating lymphocytes in human renal cell cancer: isolation, characterization, and antitumor activity. Cancer Res (1988) 1.48

Liver sinusoidal endothelial cells are insufficient to activate T cells. J Immunol (2004) 1.39

Kupffer cell suppression of CD8+ T cells in human hepatocellular carcinoma is mediated by B7-H1/programmed death-1 interactions. Cancer Res (2009) 1.39

Interleukin-17-producing cell infiltration in the breast cancer tumour microenvironment is a poor prognostic factor. Histopathology (2013) 1.35

High expression of IL-17 and IL-17RE associate with poor prognosis of hepatocellular carcinoma. J Exp Clin Cancer Res (2013) 1.24

Regulatory T cell infiltration predicts outcome following resection of colorectal cancer liver metastases. Ann Surg Oncol (2012) 1.24

MHC class I down-regulation: tumour escape from immune surveillance? (review). Int J Oncol (2004) 1.20

T cell infiltrate predicts long-term survival following resection of colorectal cancer liver metastases. Ann Surg Oncol (2009) 1.20

Liver NKT cells: an account of heterogeneity. Trends Immunol (2003) 1.16

Intratumoral IL-17⁺ cells and neutrophils show strong prognostic significance in intrahepatic cholangiocarcinoma. Ann Surg Oncol (2012) 1.08

TNFα and IL-17 cooperatively stimulate glucose metabolism and growth factor production in human colorectal cancer cells. Mol Cancer (2013) 1.04

Role of Foxp3-positive tumor-infiltrating lymphocytes in the histologic features and clinical outcomes of hepatocellular carcinoma. Am J Surg Pathol (2012) 0.97

Detection and functional analysis of tumor infiltrating T-lymphocytes (TIL) in liver metastases from colorectal cancer. Ann Surg Oncol (2008) 0.96

Interaction of B7-H1 on intrahepatic cholangiocarcinoma cells with PD-1 on tumor-infiltrating T cells as a mechanism of immune evasion. J Surg Oncol (2009) 0.94

Tumor-infiltrating macrophages can predict favorable prognosis in hepatocellular carcinoma after resection. J Cancer Res Clin Oncol (2008) 0.92

Conventional liver CD4 T cells are functionally distinct and suppressed by environmental factors. Hepatology (2005) 0.92

Shedding LIGHT (TNFSF14) on the tumor microenvironment of colorectal cancer liver metastases. J Transl Med (2013) 0.91

Prognostic impact of tumour-infiltrating immune cells on biliary tract cancer. Br J Cancer (2013) 0.90

Dendritic cells, T-cell infiltration, and Grp94 expression in cholangiocellular carcinoma. Hum Pathol (2004) 0.87

T cell infiltrate and outcome following resection of intermediate-grade primary neuroendocrine tumours and liver metastases. HPB (Oxford) (2010) 0.87

Local immune response predicts survival in patients with thick (t4) melanomas. Ann Surg Oncol (2013) 0.86

Critical role of spatial interaction between CD8⁺ and Foxp3⁺ cells in human gastric cancer: the distance matters. Cancer Immunol Immunother (2013) 0.86

Intrahepatic interleukin-17+ T cells and FoxP3+ regulatory T cells cooperate to promote development and affect the prognosis of hepatocellular carcinoma. J Gastroenterol Hepatol (2014) 0.86

Immunotherapy for solid tumors--a review for surgeons. J Surg Res (2013) 0.83

Systemic treatment of neuroendocrine tumors with hepatic metastases. Turk J Gastroenterol (2012) 0.79

[Relationship between dendritic cells and memory T lymphocytes in tumor site and prognosis of hepatocellular carcinoma]. Zhonghua Yi Xue Za Zhi (2005) 0.76